Douglas E. Kiehl
Eli Lilly & Company
Indiana, United States
Douglas Kiehl has over 39 years’ experience with application of advanced mass spectrometry in characterization of diverse chemical entities. He is a member of the USP Packaging and Distribution Expert Committee, Chair for the PQRI (Product Quality Research Institute) Development Technical Committee, PhRMA Topic Lead for the ICH Q3E Expert Working Group, Board of Directors for the ELSIE (Extractables/Leachables Safety Information Exchange) Consortium, and Chair for the SPIE Defense and Commercial Sensing Conference.
His research interests include exploring MS-based visualization techniques for rapid, comprehensive characterization of complex mixtures of structurally and compositionally diverse chemical entities. He leads efforts to advance threat detection and ultrarapid development and deployment of pharmaceutical countermeasures for catastrophic and unanticipated medical needs and point-of-use patient therapies.
